Acadia Healthcare Company, Inc.ACHCNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +8.70% | +4.23% | +0.32% | +9.19% | +4.41% |
| Gross Profit Growth | +8.69% | +337.12% | +43.87% | +340.71% | +4.47% |
| EBITDA Growth | +0.00% | -32.92% | -45.09% | -21.87% | -25.32% |
| Operating Income Growth | +0.00% | -17.26% | -89.55% | -0.29% | -18.80% |
| Net Income Growth | +0.00% | -43.50% | -89.04% | -61.61% | -46.80% |
| EPS Growth | +0.00% | -42.86% | -89.29% | -61.63% | -45.95% |
| EPS Diluted Growth | +0.00% | -44.44% | -89.16% | -61.18% | -45.95% |
| Weighted Average Shares Growth | +0.61% | +0.58% | +0.32% | -1.42% | -1.42% |
| Weighted Average Shares Diluted Growth | +1.12% | +0.12% | +0.03% | -1.75% | -1.74% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +18.33% | +0.34% | +0.00% | -21.99% | -55.12% |
| Free Cash Flow Growth | -376.44% | +0.00% | +0.00% | -302.55% | +0.00% |
| Receivables Growth | -5.18% | -1.76% | -0.65% | -4.24% | +2.79% |
| Inventory Growth | +0.71% | +6.68% | -0.61% | -2.86% | +13.29% |
| Asset Growth | +9.81% | +11.16% | +11.43% | +11.10% | +9.24% |
| Book Value per Share Growth | +11.09% | +9.85% | +5.79% | +5.74% | +4.42% |
| Debt Growth | +33.25% | +38.03% | +17.16% | +20.87% | +20.74% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +8.33% | +964.41% | +0.04% | +971.78% | +7.43% |